Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Time course of serum collagen types I and III metabolism products after reperfused acute myocardial infarction in patients with and without systemic hypertension

Abstract

We examined 55 consecutive patients successfully treated with primary percutaneous coronary intervention (PCI) for a first acute myocardial infarction with left ventricular (LV) systolic dysfunction. In all patients we performed echocardiographic examination, dosage of plasma brain natriuretic peptide, serum carboxy-terminal propeptide and telopeptide of procollagen type I and amino-terminal propeptide of procollagen type III at days 1 and 3, and at 1 and 6 months after index infarction. The hypertensive patients (group 1; n=30) differed for higher baseline blood pressure (133±4 mm Hg vs 118±4 mm Hg; P=0.03), greater LV mass index (108±5 vs 94±4 g m−2, P=0.03) and lower mitral E/A wave peak (0.8±0.06 vs 1.1±0.12, P=0.02) with respect to non-hypertensive patients (group 2; n=25). From day 1 to month 6 carboxy-terminal propeptide of procollagen type I and amino-terminal propeptide of procollagen type III increased (P<0.005 and P<0.05, respectively) in both groups, whereas carboxy-terminal telopeptide of procollagen type I increased from day 1 to day 3 (P<0.01 in both groups, respectively) and then decreased from day 3 to month 6 (P<0.01 and P<0.05 in both groups, respectively). From day 1, brain natriuretic peptide decreased in both groups (P<0.005). There was no significant difference between the two groups in values of procollagens and natriuretic peptide. Finally, LV diastolic volume and function at 6 months were similar in the two groups. Thus, in patients with reperfused acute myocardial infarction and LV dysfunction, antecedent hypertension was not associated with a different pattern of serum procollagen release and ventricular remodelling at 6 months of follow-up.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  1. Pfeffer MA, Braunwald E . Ventricular remodeling after myocardial infarction: experimental observation and clinical implications. Circulation 1990; 81: 1161–1172.

    Article  CAS  Google Scholar 

  2. Jugdutt BI . Ventricular remodeling after infarction and the extracellular collagen matrix. When is enough enough? Circulation 2003; 108: 1395–1403.

    Article  Google Scholar 

  3. Ganau A, Devereux RB, Roman MJ, de Simone G, Pickering TG, Saba PS et al. Patterns of left ventricular hypertension and geometric remodeling in essential hypertension. J Am Coll Cardiol 1992; 19: 1550–1558.

    Article  CAS  Google Scholar 

  4. Weber RT . Fibrosis and hypertensive heart disease. Curr Opin Cardiol 2000; 15: 1388–1393.

    Article  Google Scholar 

  5. Richards AM, Nicholis GM, Troughton RW, Lainchbury JG, Elliot J, Frampton C et al. Antecedent Hypertension and heart failure after myocardial infarction. J Am Coll Cardiol 2002; 39: 1182–1188.

    Article  Google Scholar 

  6. Parodi G, Carrabba N, Santoro GM, Memisha G, Valenti R, Buonamici P et al. Heart failure and left ventricular remodeling after reperfused acute myocardial infarction in patients with hypertension. Hypertension 2006; 47: 706–710.

    Article  CAS  Google Scholar 

  7. Kenchaia S, Pfeffer MA, St John SM, Plappert T, Rouleau JL, Lamas GA et al. Effect of antecedent systemic hypertension on subsequent left ventricular dilation after acute myocardial infarction (from the Survival and Ventricular Enlargement Trial). Am J Cardiol 2004; 94: 1–8.

    Article  Google Scholar 

  8. Uusimaa P, Risteli J, Niemela M, Lumme J, Ikaheimo M, Jounela A et al. Collagen scar formation after acute myocardial infarction: relationships to infarct size, left ventricular function, and coronary artery patency. Circulation 1997; 96: 2565–2572.

    Article  CAS  Google Scholar 

  9. Magga J, Puhakka M, Hietakorpi S, Punnonen K, Uusimaa P, Risteli J et al. Atrial natriuretic peptide, B-type natriuretic peptide and serum collagen markers after acute myocardial infarction. J Appl Physiol 2004; 96: 1306–1311.

    Article  CAS  Google Scholar 

  10. Cerisano G, Pucci PD, Sulla A, Tommasi MS, Raspanti S, Santoro GM et al. Relationship between plasma brain natriuretic peptide, serum indexes of collagen type I turnover, and left ventricular remodeling after reperfused acute myocardial infarction. Am J Cardiol 2007; 99: 651–656.

    Article  CAS  Google Scholar 

  11. Diez J, Lavadies C, Mayor G, Gil MJ, Monreal I . Increased serum concentrations of procollagen peptides in essential hypertension. Relation to cardiac alterations. Circulation 1995; 91: 1450–1456.

    Article  CAS  Google Scholar 

  12. Querejeta R, Varo N, Lopez B, Larman M, Artiñano E, Etayo JC et al. Serum Carboxy-terminal propeptide of procollagen type I is a marker of myocardial fibrosis in hypertensive heart disease. Circulation 2000; 101: 1729–1735.

    Article  CAS  Google Scholar 

  13. Diez J, Querejata R, López B, Gonzáles A, Larman M, Martinez Ubago JL . Losartan-dependent regression of myocardial fibrosis is associated with reduction of left ventricular chamber stiffness in hypertensive patients. Circulation 2002; 105: 2512–2517.

    Article  CAS  Google Scholar 

  14. Querejata R, López B, Gonzáles A, Sánchez E, Larman M, Martinez Ubago JL et al. Increased collagen type I synthesis in patients with heart failure of hypertensive origin. Relation to myocardial fibrosis. Circulation 2004; 110: 1263–1268.

    Article  Google Scholar 

  15. Eghbali M, Czaja MJ, Zeydel M, Weiner FR, Zern MA, Seifter S et al. Collagen chain mRNAs in isolated heart cells from young and adult rats. J Mol Cell Cardiol 1989; 21: 103–113.

    Article  CAS  Google Scholar 

  16. Volpi A, De Vita C, Franzosi MG, Geraci E, Maggioni AP, Mauri F et al. Determinants of 6-month mortality in survivors of myocardial infarction after thrombolysis. Results of the GISSI-2 data base. The Ad hoc Working Group of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-2 Data Base. Circulation 1993; 88: 416–429.

    Article  CAS  Google Scholar 

  17. Cerisano G, Bolognese L, Carrabba N, Buonamici P, Santoro GM, Antoniucci D et al. Doppler-derived mitral deceleration time. An early strong predictor of left ventricular remodeling after reperfused anterior acute myocardial infarction. Circulation 1999; 99: 230–236.

    Article  CAS  Google Scholar 

  18. Weber KT . Fibrosis and hypertensive heart disease. Curr Opin Cardiol 2000; 15: 1388–1393.

    Article  Google Scholar 

  19. Pfeffer MA, McMurray JJV, Velazquez EJ, Rouleau JL, Køber L, Maggioni AP et al. Valsartan, Captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. N Engl J Med 2003; 349: 1893–1906.

    Article  CAS  Google Scholar 

  20. Webb CS, Bonnema DD, Ahemed SH, Leonardi AH, McClure CD, Clark LL et al. Specific temporal profile of matrix metalloproteinase release occurs in patients after myocardial infarction: relation to left ventricular remodeling. Circulation 2006; 114: 1020–1027.

    Article  CAS  Google Scholar 

  21. Høst NB, Jensen LT, Bendixen PM, Jensen SE, Koldkjaer OG, Simonsen EE . The aminoterminal propeptide of type III procollagen provides new information on prognosis after acute myocardial infarction. Am J Cardiol 1995; 76: 869–873.

    Article  Google Scholar 

  22. Peuhkurinen KJ, Risteli L, Melkko JT, Linnaluoto M, Jounela A, Risteli J . Thrombolytic therapy with streptokinase stimulates collagen breakdown. Circulation 1991; 83: 1969–1975.

    Article  CAS  Google Scholar 

  23. Wang TJ, Larson MG, Benjamin EJ, Siwik DA, Safa R, Guo C-Y et al. Clinical and echocardiographic correlates of plasma procollagen type III amino-terminal peptide levels in the community. Am Heart J 2007; 154: 291–297.

    Article  CAS  Google Scholar 

  24. Mukherjee R, Widener CE, Brinsa TA, Dowdy KB, Scott AA, Sample JA et al. Myocardial infarct expansion and matrix metalloproteinase inhibition. Circulation 2003; 107: 618–625.

    Article  CAS  Google Scholar 

  25. Wilson EM, Moainie SL, Bakin JM, Lowry AS, Deschamps AM, Mukherjee R et al. Region and species specific induction of matrix metalloproteinases occurs with post-myocardial infarction remodeling. Circulation 2003; 107: 2857–2863.

    Article  CAS  Google Scholar 

  26. Yabrough WM, Mukherjee R, Escobar GP, Mingoia JT, Sample JA, Hendrick JW et al. Selective targeting and timing of matrix metalloproteinase inhibition in post-myocardial infarction remodeling. Circulation 2003; 108: 1753–1759.

    Article  Google Scholar 

  27. Lopez A, Querejta R, Gonzales A, Sanchez E, Larman M, Diez J . Effects of loop diuretics on myocardial fibrosis and collagen type I turnover in chronic heart failure. J Am Coll Cardiol 2004; 43: 2028–2035.

    Article  CAS  Google Scholar 

  28. Vogt M, Strauer BE . Systolic ventricular dysfunction and heart failure due to coronary microangiopathy in hypertensive heart disease. Am J Cardiol 1995; 76: 48D–53D.

    Article  CAS  Google Scholar 

  29. Kawaguchi M, Hay I, Fetics B, Kass DA . Combined ventricular systolic and arterial stiffening in patients with heart failure and preserved ejection fraction. Implications for systolic and diastolic reserve limitations. Circulation 2003; 107: 714–720.

    Article  Google Scholar 

Download references

Acknowledgements

This study was supported by a research grant from the A.R. CARD ONLUS Foundation, Florence, Italy and by an unrestricted grant from Cassa di Risparmio di Firenze Foundation, Italy.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to G Cerisano.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cerisano, G., Parodi, G., Dovellini, E. et al. Time course of serum collagen types I and III metabolism products after reperfused acute myocardial infarction in patients with and without systemic hypertension. J Hum Hypertens 23, 40–47 (2009). https://doi.org/10.1038/jhh.2008.98

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/jhh.2008.98

Keywords

Search

Quick links